MediSel: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MediSel
Largest movements
- Cash +€18,437
up €18,437 (+28.3%), from €65,183 to €83,619
mainly Net result for the year (+€25,016) and Depreciation (+€7,315)
- Tangible fixed assets -€7,315
down €7,315 (-100.0%), from €7,315 to €0
- Receivables within one year +€1,290
up €1,290 (+15.2%), from €8,505 to €9,794
of which Other amounts receivable: +€810
- Reserves +€25,016
up €25,016 (+45.7%), from €54,734 to €79,750
- Tax, wage and social debts -€12,328
down €12,328 (-100.0%), from €12,328 to €0
- Gross operating margin -€12,613
down €12,613 (-24.3%), from €52,003 to €39,390
- Taxes -€6,014
down €6,014 (-48.8%), from €12,333 to €6,319
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €81,002 | €93,414 | +€12,411 | +15.3% |
| Fixed assets | 21/28 | €7,315 | €0 | -€7,315 | -100.0% |
| Tangible fixed assets | 22/27 | €7,315 | €0 | -€7,315 | -100.0% |
| Furniture and vehicles | 24 | €7,315 | €0 | -€7,315 | -100.0% |
| Current assets | 29/58 | €73,687 | €93,414 | +€19,726 | +26.8% |
| Amounts receivable within one year | 40/41 | €8,505 | €9,794 | +€1,290 | +15.2% |
| Trade receivables | 40 | €8,505 | €8,984 | +€480 | +5.6% |
| Other amounts receivable | 41 | - | €810 | +€810 | |
| Cash at bank and in hand | 54/58 | €65,183 | €83,619 | +€18,437 | +28.3% |
| Deferred charges and accrued income | 490/1 | €0 | - | = | |
| Total equity and liabilities | 10/49 | €81,002 | €93,414 | +€12,411 | +15.3% |
| Equity | 10/15 | €56,234 | €81,250 | +€25,016 | +44.5% |
| Contributions | 10/11 | €1,500 | €1,500 | = | 0.0% |
| Reserves | 13 | €54,734 | €79,750 | +€25,016 | +45.7% |
| Distributable reserves | 133 | €54,734 | €79,750 | +€25,016 | +45.7% |
| Amounts payable | 17/49 | €24,768 | €12,163 | -€12,605 | -50.9% |
| Amounts payable within one year | 42/48 | €24,768 | €12,163 | -€12,605 | -50.9% |
| Trade debts | 44 | €11,441 | €11,156 | -€285 | -2.5% |
| Suppliers | 440/4 | €11,441 | €11,156 | -€285 | -2.5% |
| Taxes, remuneration and social security | 45 | €12,328 | €0 | -€12,328 | -100.0% |
| Taxes | 450/3 | €12,328 | €0 | -€12,328 | -100.0% |
| Other amounts payable | 47/48 | €999 | €1,007 | +€8 | +0.8% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €7,315 | €7,315 | = | 0.0% |
| Other operating charges | 640/8 | €558 | €984 | +€426 | +76.3% |
| Gross operating margin | 9900 | €52,003 | €39,390 | -€12,613 | -24.3% |
| Operating profit (loss) | 9901 | €44,129 | €31,090 | -€13,039 | -29.5% |
| Financial income | 75/76B | €17 | €435 | +€418 | +2464.7% |
| Recurring financial income | 75 | €17 | €435 | +€418 | +2464.7% |
| Financial charges | 65/66B | €161 | €190 | +€29 | +18.0% |
| Recurring financial charges | 65 | €161 | €190 | +€29 | +18.0% |
| Profit (loss) for the period before taxes | 9903 | €43,985 | €31,335 | -€12,650 | -28.8% |
| Income taxes | 67/77 | €12,333 | €6,319 | -€6,014 | -48.8% |
| Profit (loss) for the period | 9904 | €31,652 | €25,016 | -€6,636 | -21.0% |
| Profit (loss) for the period to be appropriated | 9905 | €31,652 | €25,016 | -€6,636 | -21.0% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 29 September 2026 via checked.be.